WASHINGTON, March 31 (Reuters) – The amount of money big U.S. pharmaceutical manufacturers have paid to settle charges for violating federal health care laws has declined sharply in recent years,…
The post Decline in financial settlements with U.S. Big Pharma -report appeared first on NASDAQ.